ATP can bind to the SUR subunits to inhibit KATP channel activity and regulate a series of biochemical systems, similarly, sulfonylureas, which are widely used in the treatment of type 2 diabetes mellitus as a ligand of SUR, bind to the SUR subunit in multiple locations so as to inhibit KATP channel activity too. This evidence concerns the gene ABCC8 and diabetes mellitus.